GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Ltd (BOM:524652) » Definitions » Market Cap

Ind-Swift (BOM:524652) Market Cap : ₹1,181 Mil (As of Jun. 25, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ind-Swift Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ind-Swift's share price for the quarter that ended in Mar. 2024 was ₹18.3. Ind-Swift's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 54 Mil. Therefore, Ind-Swift's market cap for the quarter that ended in Mar. 2024 was ₹991 Mil.

Ind-Swift's quarterly market cap declined from Sep. 2023 (₹1,041 Mil) to Dec. 2023 (₹968 Mil) but then increased from Dec. 2023 (₹968 Mil) to Mar. 2024 (₹991 Mil).

Ind-Swift's annual market cap declined from Mar. 2022 (₹606 Mil) to Mar. 2023 (₹391 Mil) but then increased from Mar. 2023 (₹391 Mil) to Mar. 2024 (₹991 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ind-Swift's Enterprise Value for Today is ₹10,689 Mil.


Ind-Swift Market Cap Historical Data

The historical data trend for Ind-Swift's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Market Cap Chart

Ind-Swift Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.58 246.45 606.10 391.07 991.21

Ind-Swift Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.07 673.27 1,040.50 968.46 991.21

Competitive Comparison of Ind-Swift's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift's Market Cap distribution charts can be found below:

* The bar in red indicates where Ind-Swift's Market Cap falls into.



Ind-Swift Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ind-Swift's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹18.3*54.1646
=₹991

Ind-Swift's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹18.3*54.1646
=₹991

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift  (BOM:524652) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ind-Swift Market Cap Related Terms

Thank you for viewing the detailed overview of Ind-Swift's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Ind-Swift (BOM:524652) Business Description

Traded in Other Exchanges
Address
781, Industrial Area, Phase II, Chandigarh, IND, 160002
Ind-Swift Ltd is an India-based pharmaceutical company. It engages in the manufacturing and marketing of pharmaceutical products. The company's products are classified into divisions namely, Generic Division, NOVA Division, Ethical Division, Nobel Division, Herba Plus Division, Institution Division, and Proposed Division. The manufacturing facilities of the firm are situated in (Derabassi)Punjab, India. Substantial revenue accrues from export sales of products.

Ind-Swift (BOM:524652) Headlines

No Headlines